Wissenschaftliche Publikationen Suche Suche Autor/in Forschungsgruppe Veröffentlichungsdatum Wirkungsfaktor Suchen Sortieren nach RelevanceFrom A-ZAuthored onDate/Time RangeRelease date Reihenfolge AufsteigendAbsteigend Akalin, Altuna Dr. (1) Bernert, Carola (1) Beule, Dieter Dr. (2) Bock-Bierbaum, Tobias Dr. (2) Cakmak-Görür, Nese Dr. (1) Coralluzzo, Violeta (1) Daniel, Peter Prof. Dr. (1) Daumke, Oliver Prof. Dr. (19) Dechend, Ralf Priv. Doz. (1) Dhamodaran, Arunraj (1) Di Virgilio, Michela Prof. Dr. (1) Fälber, Katja Dr. (2) Franke, Vedran Dr. (1) Geisberger, Sabrina Yasmin Dr. (1) Haucke, Volker Professor (2) Hinz, Michael Dr. (1) Höpken, Uta Elisabeth PD Dr. (1) Hübner, Norbert Prof. Dr. (1) Kammertöns, Thomas Dr. (6) Kolesnichenko, Marina Dr. (1) Kopp, Joachim Dr. (1) Kudryashev, Mikhail Prof. Dr. (1) Kunz, Severine Dr. (2) Lahmann, Ines Dr. (1) Leisegang, Matthias Prof. Dr. rer. nat. (2) Lewin, Gary Prof. Dr. (2) Lorenz, Felix Dr. (1) Marg, Andreas Dr. (1) Marko, Lajos Dr. (1) Müller, Dominik Prof. Dr. (2) Müller, Gerd Dr. (1) Noel, Jeffrey Dr. (4) Patone, Giannino Dr. (1) Pezzutto, Antonio Prof. Dr. (2) Poncette, Lucia (1) Rhein, Simone Dr. (1) Saha, Tannishtha (1) Scheidereit, Claus Prof. Dr. (1) Schlegel, Jeanette (2) Schmitt, Clemens Prof. Dr. (1) Selbach, Matthias Prof. Dr. (1) Siffrin, Volker (1) Spuler, Simone Prof. (1) Uckert, Wolfgang Prof. Dr. (2) Willimsky, Gerald Dr. (2) Witt, Marie Dr. (2) Yilmaz, Zekiye Buket Dr. (1) (-) Blankenstein, Thomas Prof. Dr. (15) (-) Mathas, Stephan Dr. (1) Bioinformatics and Omics Data Science (1) Biologie maligner Lymphome (9) Genetik und Genomik von Herz- Kreislauferkrankungen (1) Immunregulation und Krebs (1) (-) Molekulare Immunologie und Gentherapie (15) Proteom Dynamik (1) (-) Strukturbiologie Membran-assoziierter Prozesse (1) Systembiologie von Gen-regulatorischen Elementen (1) Translational Bioinformatics (2) Tumorgenetik und zelluläre Stressantworten (1) 1992 (4) 1993 (7) 1994 (5) 1995 (8) 1996 (6) 1997 (9) 1998 (9) 1999 (2) 2000 (8) 2001 (5) 2002 (5) 2003 (9) 2004 (8) 2005 (10) 2006 (1) 2007 (5) 2008 (5) 2009 (2) 2010 (7) 2011 (5) (-) 2012 (6) 2013 (12) 2014 (3) (-) 2015 (3) 2016 (4) 2017 (6) 2018 (5) (-) 2019 (7) 2021 (4) 2022 (6) 2023 (6) 2024 (2) 16 Ergebnisse: Active Filter: Blankenstein, Thomas Prof. Dr.Mathas, Stephan Dr.Molekulare Immunologie und Gentherapie Strukturbiologie Membran-assoziierter Prozesse201220152019 Sortieren: Treffgenauigkeit Neueste nach älteste Älteste nach neueste 30. März 2012 / PLoS ONE Stromal interferon-γ signaling and cross-presentation are required to eliminate antigen-loss variants of B cell lymphomas in mice A. Gerbitz M. Sukumar F. Helm A. Wilke C. Friese C. Fahrenwaldt F.M. Lehmann C. Loddenkemper T. Kammertoens J. Mautner C.A. Schmitt T. Blankenstein G.W. Bornkamm 01. Dezember 2012 / Cytokine Differences in serum cytokine levels between wild type mice and mice with a targeted mutation suggests necessity of using control littermates D. Briesemeister C. Friese C.C. Isern E. Dietz T. Blankenstein C. Thoene-Reineke T. Kammertoens 01. April 2015 / Nat Biotechnol Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice M. Obenaus C. Leitão M. Leisegang X. Chen I. Gavvovidis P. van der Bruggen W. Uckert D.J. Schendel T. Blankenstein 01. November 2012 / Arzneimittelforschung Spontaneous and therapy-induced T cell responses to cancer T. Blankenstein 01. April 2015 / Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber 15. April 2015 / Int J Cancer Gene expression profiling of peripheral blood mononuclear cells during treatment with a gene-modified allogeneic tumor cell vaccine in advanced renal cell cancer: tumor-induced immunosuppression and a possible role for NF-κB A. Flörcken M. Grau A. Wolf A. Weilemann J. Kopp B. Dörken T. Blankenstein A. Pezzutto P. Lenz G. Lenz J. Westermann 01. April 2012 / Nat Rev Cancer The determinants of tumour immunogenicity T. Blankenstein P.G. Coulie E. Gilboa E.M. Jaffee 27. November 2019 / BMC Med Genomics Identification and ranking of recurrent neo-epitopes in cancer E. Blanc M. Holtgrewe A. Dhamodaran C. Messerschmidt G. Willimsky T. Blankenstein D. Beule 24. März 2019 / OncoImmunology Localization-associated immune phenotypes of clonally expanded tumor-infiltrating T cells and distribution of their target antigens in rectal cancer L. Penter K. Dietze J. Ritter M.F. Lammoglia Cobo J. Garmshausen F. Aigner L. Bullinger H. Hackstein S. Wienzek-Lischka T. Blankenstein M. Hummel K. Dornmair L. Hansmann 02. Januar 2019 / J Clin Invest Effective NY-ESO-1-specific MHC II-restricted T cell receptors from antigen-negative hosts enhance tumor regression L. Poncette X. Chen F.K.M. Lorenz T. Blankenstein Seitennummerierung Aktuelle Seite 1 Seite 2 Nächste Seite Next › Letzte Seite Last »
30. März 2012 / PLoS ONE Stromal interferon-γ signaling and cross-presentation are required to eliminate antigen-loss variants of B cell lymphomas in mice A. Gerbitz M. Sukumar F. Helm A. Wilke C. Friese C. Fahrenwaldt F.M. Lehmann C. Loddenkemper T. Kammertoens J. Mautner C.A. Schmitt T. Blankenstein G.W. Bornkamm
01. Dezember 2012 / Cytokine Differences in serum cytokine levels between wild type mice and mice with a targeted mutation suggests necessity of using control littermates D. Briesemeister C. Friese C.C. Isern E. Dietz T. Blankenstein C. Thoene-Reineke T. Kammertoens
01. April 2015 / Nat Biotechnol Identification of human T-cell receptors with optimal affinity to cancer antigens using antigen-negative humanized mice M. Obenaus C. Leitão M. Leisegang X. Chen I. Gavvovidis P. van der Bruggen W. Uckert D.J. Schendel T. Blankenstein
01. November 2012 / Arzneimittelforschung Spontaneous and therapy-induced T cell responses to cancer T. Blankenstein
01. April 2015 / Curr Opin Immunol Targeting cancer-specific mutations by T cell receptor gene therapy T. Blankenstein M. Leisegang W. Uckert H. Schreiber
15. April 2015 / Int J Cancer Gene expression profiling of peripheral blood mononuclear cells during treatment with a gene-modified allogeneic tumor cell vaccine in advanced renal cell cancer: tumor-induced immunosuppression and a possible role for NF-κB A. Flörcken M. Grau A. Wolf A. Weilemann J. Kopp B. Dörken T. Blankenstein A. Pezzutto P. Lenz G. Lenz J. Westermann
01. April 2012 / Nat Rev Cancer The determinants of tumour immunogenicity T. Blankenstein P.G. Coulie E. Gilboa E.M. Jaffee
27. November 2019 / BMC Med Genomics Identification and ranking of recurrent neo-epitopes in cancer E. Blanc M. Holtgrewe A. Dhamodaran C. Messerschmidt G. Willimsky T. Blankenstein D. Beule
24. März 2019 / OncoImmunology Localization-associated immune phenotypes of clonally expanded tumor-infiltrating T cells and distribution of their target antigens in rectal cancer L. Penter K. Dietze J. Ritter M.F. Lammoglia Cobo J. Garmshausen F. Aigner L. Bullinger H. Hackstein S. Wienzek-Lischka T. Blankenstein M. Hummel K. Dornmair L. Hansmann
02. Januar 2019 / J Clin Invest Effective NY-ESO-1-specific MHC II-restricted T cell receptors from antigen-negative hosts enhance tumor regression L. Poncette X. Chen F.K.M. Lorenz T. Blankenstein